About me
As Chief Strategy Officer of Astellas Pharma, Adam Pearson plays a pivotal role in shaping the company’s corporate strategy, spearheading initiatives in business planning, the development and execution of Primary Focus strategies, business partnerships, Rx+ business creation, Patient Centricity, and sustainability efforts. Adam joined Yamanouchi (now Astellas) in 2004 after his tenure at Boston Consulting Group and has held several prominent positions at the company before his appointment as CStO in April 2023. With over 20 years of experience in strategic and operational roles within the life sciences sector, Adam has held key leadership roles across various countries, regions, divisions, and functions. He is also a strong advocate for patient centricity, drawing from his personal experiences as a patient.
